Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
2.280
-0.050 (-2.15%)
Aug 29, 2025, 4:00 PM - Market closed
Elutia Employees
Elutia had 51 employees as of December 31, 2024. The number of employees decreased by 3 or -5.56% compared to the previous year.
Employees
51
Change (1Y)
-3
Growth (1Y)
-5.56%
Revenue / Employee
$464,373
Profits / Employee
-$418,000
Market Cap
96.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | -3 | -5.56% |
| Dec 31, 2023 | 54 | -110 | -67.07% |
| Dec 31, 2022 | 164 | -12 | -6.82% |
| Dec 31, 2021 | 176 | 13 | 7.98% |
| Dec 31, 2020 | 163 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELUT News
- 3 days ago - Elutia to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Elutia Inc. (ELUT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption - GlobeNewsWire
- 4 weeks ago - Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewsWire
- 4 weeks ago - Dr. Michelle LeRoux Williams Earns Washington Business Journal's Medical Device Innovator Award - GlobeNewsWire
- 2 months ago - New Evidence Supports the Value of Elutia's Antibiotic-Eluting Platform for Implantable Devices - GlobeNewsWire
- 2 months ago - Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards - GlobeNewsWire
- 3 months ago - Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method - GlobeNewsWire